Skip to main content

Table 1 Differences of the clinicopathological features in RCS subgroups

From: A combined preoperative red cell distribution width and carcinoembryonic antigen score contribute to prognosis prediction in stage I lung adenocarcinoma

Features

Patient No

RCS

 
  

RCS 1

RCS 2

RCS 3

P

Age (years)

    

 < 0.001*

  < 60

90

52

33

5

 

  ≥ 60

64

18

32

14

 

Gender

    

0.004*

 Male

77

25

39

13

 

 Female

77

45

26

6

 

Type of resection

    

0.788

 Lobectomy

114

50

50

14

 

 Segmentectomy

40

20

15

5

 

Micropapillary or solid component

    

0.830

 Without or unknown

120

56

50

14

 

 With

34

14

15

5

 

Tobacco use history

    

0.001*

 Never

119

63

45

11

 

 Current + former

35

7

20

8

 

Alcohol use history

    

0.972

 Never

100

45

43

12

 

 Current + former

54

25

22

7

 

Hypertension

    

0.060

 Without

119

60

45

14

 

 With

35

10

20

5

 

Combined T stages

    

0.004*

 T1

123

63

49

11

 

 T2

31

7

16

8

 

TNM stages

    

0.006*

 IA

124

63

50

11

 

 IB

30

7

15

8

 
  1. *With significant statistical difference
  2. No Number, RCS Red cell distribution width and carcinoembryonic antigen score, TNM Tumor-Node-Metastasis